DermTech, Inc. short interest in 2023
In 2023, DermTech, Inc.'s disclosed short interest ran from 8.47% of shares outstanding on 13 Jan 2023 to 8.92% on 29 Dec 2023, a change of +0.45 percentage points. The year's high was 16.69% on 30 Nov 2023 and its low 8.31% on 15 Feb 2023, averaging 11.67% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.75 days on 31 Aug 2023. Full history: DermTech, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024
2023 in figures
- Start of year
- 8.47% (13 Jan 2023)
- End of year
- 8.92% (29 Dec 2023)
- Change
- +0.45 pp
- High
- 16.69% (30 Nov 2023)
- Low
- 8.31% (15 Feb 2023)
- Average
- 11.67%
- Highest days to cover
- 31.75 (31 Aug 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 8.47% | 1.76 | |
| 31 Jan 2023 | 8.63% | 2.20 | |
| 15 Feb 2023 | 8.31% | 4.48 | |
| 28 Feb 2023 | 10.31% | 5.67 | |
| 15 Mar 2023 | 10.59% | 7.03 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 11.31% | 13.14 | |
| 14 Apr 2023 | 10.56% | 10.99 | |
| 28 Apr 2023 | 10.23% | 9.08 | |
| 15 May 2023 | 9.37% | 4.00 | 10-Q filed, results (8-K) |
| 31 May 2023 | 9.09% | 10.83 | |
| 15 Jun 2023 | 10.40% | 6.98 | |
| 30 Jun 2023 | 11.70% | 8.59 | |
| 14 Jul 2023 | 12.48% | 12.72 | |
| 31 Jul 2023 | 12.07% | 13.01 | |
| 15 Aug 2023 | 13.01% | 14.76 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 14.31% | 31.75 | |
| 15 Sep 2023 | 14.02% | 19.41 | |
| 29 Sep 2023 | 14.50% | 20.91 | |
| 13 Oct 2023 | 15.53% | 15.99 | |
| 31 Oct 2023 | 15.07% | 24.26 | |
| 15 Nov 2023 | 15.68% | 16.72 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 16.69% | 28.87 | |
| 15 Dec 2023 | 8.72% | 3.91 | |
| 29 Dec 2023 | 8.92% | 4.29 |
See also: DermTech, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.